Skip to main content
Premium Trial:

Request an Annual Quote

FlowMetric Dx Formed to Develop Flow Cytometry-based CDx

NEW YORK (GenomeWeb) – FlowMetric today announced the formation of an affiliate company, FlowMetric Diagnostics, to leverage flow cytometry technology in the development of companion diagnostics.

Doylestown, Penn.-based FlowMetric is a contract research organization that provides polychromatic flow cytometry and cell sorting services to the biopharma and drug discovery market. FlowMetric Diagnostics plans to establish a US Food and Drug Administration-compliant flow cytometry laboratory in order to run CLIA-certified diagnostic tests from its own assay portfolio and from partnering diagnostic companies.

The creation of the new firm "represents the natural progression of the FlowMetric business into the clinical marketplace and recognizes the need for additional diagnostics," FlowMetric CEO Ren Capocasale said in a statement.

Amy Williams will serve as FlowMetric Diagnostics' president, while Julie Bick will be its CSO. Capocasale will be the company's chairman.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.